abrdn Healthcare Investors (NYSE:HQH) Sees Unusually-High Trading Volume – Here’s Why

abrdn Healthcare Investors (NYSE:HQH) saw an uptick in trading volume on Friday . 159,831 shares were traded during trading, a decline of 13% from the previous session’s volume of 182,900 shares.The stock last traded at $21.4920 and had previously closed at $21.15.

abrdn Healthcare Investors Price Performance

The stock has a 50-day moving average of $20.39 and a two-hundred day moving average of $19.55.

abrdn Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Thursday, May 21st were issued a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a yield of 11.3%. The ex-dividend date was Thursday, May 21st.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Bollard Group LLC purchased a new position in shares of abrdn Healthcare Investors in the first quarter worth approximately $25,000. Geneos Wealth Management Inc. lifted its position in shares of abrdn Healthcare Investors by 9,232.3% in the 2nd quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after acquiring an additional 2,862 shares in the last quarter. Flagship Harbor Advisors LLC purchased a new stake in shares of abrdn Healthcare Investors in the 4th quarter valued at approximately $48,000. Advisory Services Network LLC purchased a new stake in shares of abrdn Healthcare Investors in the 3rd quarter valued at approximately $97,000. Finally, Global Retirement Partners LLC acquired a new position in abrdn Healthcare Investors in the 4th quarter worth approximately $106,000. 32.60% of the stock is currently owned by institutional investors and hedge funds.

abrdn Healthcare Investors Company Profile

abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.

The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.